Get started
CYBIN INC.CYBIN INC.CYBIN INC.

CYBIN INC.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

CYBN chart

Key stats

Market capitalization
‪212.24 M‬CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.28CAD
Net income
‪−47.49 M‬CAD
Revenue
—
Shares float
‪348.10 M‬
Beta (1Y)
—

About CYBIN INC.

Sector
Health Technology
CEO
Douglas L. Drysdale
Headquarters
Toronto
Website
cybin.com
Founded
2016
ISIN
CA23256X1006
FIGI
BBG00HZ0NHX4
Cybin, Inc. is a clinical-stage biopharmaceutical company. The company's mission is to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Its goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder, and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder, and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CYBN is 0.52 CAD — it has increased by 4.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange CYBIN INC. stocks are traded under the ticker CYBN.
CYBIN INC. is going to release the next earnings report on Jun 26, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for CYBIN INC. has a max estimate of 8.10 CAD and a min estimate of 5.39 CAD.
CYBN earnings for the last quarter are −0.05 CAD whereas the estimation was −0.05 CAD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.04 CAD. See more details about CYBIN INC. earnings.
Yes, you can track CYBIN INC. financials in yearly and quarterly reports right on TradingView.
CYBN stock has fallen by 7.14% compared to the previous week, the month change is a 11.86% fall, over the last year CYBIN INC. has showed a 8.33% increase.
CYBN net income for the last quarter is ‪−30.33 M‬ CAD, while the quarter before that showed ‪−11.89 M‬ CAD of net income which accounts for −155.09% change. Track more CYBIN INC. financial stats to get the full picture.
No, CYBN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYBN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYBIN INC. stock right from TradingView charts — choose your broker and connect to your account.
CYBN reached its all-time high on Jul 27, 2021 with the price of 4.00 CAD, and its all-time low was 0.30 CAD and was reached on Jun 7, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYBIN INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYBIN INC. stock shows the sell signal. See more of CYBIN INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CYBIN INC. future price: according to them, CYBN price has a max estimate of 8.10 CAD and a min estimate of 5.39 CAD. Read a more detailed CYBIN INC. forecast: see what analysts think of CYBIN INC. and suggest that you do with its stocks.